Siric > Platforms > Clinical Research

Clinical research is an essential component of the therapeutic progress in cancerology. It is positioned at the interface between the world of care and that of research and helps patients to benefit from recent diagnostic and therapeutic innovations.

The clinical research activity conducted at the Montpellier Regional Cancer Institute (ICM ) and at the University Hospital of Montpellier is multidisciplinary, involving all organ pathologies and all therapeutic modalities used in cancer treatment.

The assessments focus on anticancer molecules, radiotherapy techniques, surgery, imaging, diagnosis, and on supportive care and new research strategies in human and social sciences.
Strong national recognition

Montpellier’s clinical cancer research is well developed and has been structured over the years to incorporate an ongoing commitment to quality, ethics and respect for patient rights.

Delegations for Clinical Research and Innovation (DRCI)

The DRCIs attached to Montpellier University Hospital and ICM play a major role in the organisation and development of quality biomedical research in oncology. The diverse skills of the DRCI teams actively promote clinical research and are charged with the mission of providing information, incentives and methodological support via the hospital team.

Clinical investigation structures in oncology

Structures specific to oncology, and agreed by the Ministry of Health and the Clinical Research Centre of ICM, offer extensive therapeutic trial capacity.

Within it, the early phase clinical trial Centre (CLIP2), as defined by the INCa in a project carried out in conjunction with Montpellier University Hospital (CHRU), constitutes a platform for conducting phase I and II clinical trials for all tumour types except for pediatrics.

The Languedoc-Roussillon cancerology clinical research platform

The Languedoc-Roussillon cancerology clinical research platform aims to improve the visibility and quality of clinical trials conducted in the region. For health professionals, this digital, online platform aims for a wide referencing of clinical trials with improved opportunities for patient inclusion. In addition, enrolment in the platform will allow professionals to be better informed and supported in the development of new trials.